Bladder cancer has been billed by AstraZeneca as a key growth area for its immunotherapy Imfinzi, an ambition that has now been buoyed by the results of the VOLGA trial. VOLGA was conducted in ...
Pursuant to federal law, government-produced materials appearing on this site are not copyright protected. The United States Government may receive and hold copyrights transferred to it by assignment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results